Fondata nel 1998 da Leonard A. e Ronald S. Lauder per finanziare gli scienziati più promettenti del mondo accademico e non, nello sviluppo di nuovi farmaci e clinical trials per l’Alzheimer ed altre tipologie di demenza correlate., l’Alzheimer’s Drug Discovery Foundation è focalizzata sulla ricerca translazionale, per tradurre le conoscenze in medicinali, e mira a colmare la mancanza di fondi inerenti: preclinical drug discovery and early-stage clinical trials of potential drug targets, and early detection.
I bandi
![](https://ricerca2.unibs.it/wp-content/uploads/2019/04/Alzheimers-Drug-Discovery-Foundation-300x120.jpg)
Alzheimer’s Drug Discovery Foundation – Prevention pipeline
Through its Prevention beyond the pipeline Program,The ADDF seeks to support studies of cognitive symptoms due to health conditions, comparative ...
![](https://ricerca2.unibs.it/wp-content/uploads/2019/04/Alzheimers-Drug-Discovery-Foundation-300x120.jpg)
Alzheimer’s Drug Discovery Foundation – Neuroimaging and CSF Biomarker development program
Given the pathological heterogeneity of Alzheimer's disease and related dementias, new biomarkers are needed to more accurately characterize specific underlying ...
![](https://ricerca2.unibs.it/wp-content/uploads/2019/04/Alzheimers-Drug-Discovery-Foundation-300x120.jpg)
Alzheimer’s Drug Discovery Foundation – Program to Accelerate Clinical Trials (PACT)
The PACT RFP supports IND-enabling studies and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease ...
![](https://ricerca2.unibs.it/wp-content/uploads/2019/04/Alzheimers-Drug-Discovery-Foundation-300x120.jpg)
Alzheimer’s Drug Discovery Foundation – Drug Development Program
Through its Drug Development Program the ADDF seeks to support in vivo preclinical studies that advance lead molecules developed for ...
![](https://ricerca2.unibs.it/wp-content/uploads/2019/04/Alzheimers-Drug-Discovery-Foundation-300x120.jpg)
Alzheimer’s Drug Discovery Foundation – Program to Accelerate Clinical Trials (PACT)
L’obiettivo del bando è l’aumento del numero di trattamenti nuovi per la malattia di Alzheimer, le demenze correlate e l'invecchiamento cognitivo ...
![](https://ricerca2.unibs.it/wp-content/uploads/2019/04/Alzheimers-Drug-Discovery-Foundation-300x120.jpg)
Alzheimer’s Drug Discovery Foundation – Prevention beyond the pipeline
Through its Prevention beyond the pipeline Program, the ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological ...
![](https://ricerca2.unibs.it/wp-content/uploads/2019/04/Alzheimers-Drug-Discovery-Foundation-300x120.jpg)
Alzheimer’s Drug Discovery Foundation – Neuroimaging and CSF Biomarker development program
Given the pathological heterogeneity of Alzheimer's disease and related dementias, new biomarkers are needed to more accurately characterize specific underlying ...
![](https://ricerca2.unibs.it/wp-content/uploads/2019/04/Alzheimers-Drug-Discovery-Foundation-300x120.jpg)
Alzheimer’s Drug Discovery Foundation – Drug Development Program
Through its Drug Development Program the ADDF seeks to support develop therapeutics for Alzheimr's disease and related dementias. Thsi program ...
![](https://ricerca2.unibs.it/wp-content/uploads/2019/04/Alzheimers-Drug-Discovery-Foundation-300x120.jpg)
Accelerating Drug Discovery for Frontotemporal Dementias
he Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) seek to accelerate and support drug discovery ...